ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $973,000 | -93.2% | 21,505 | -91.6% | 0.00% | -92.6% |
Q2 2022 | $14,312,000 | -10.8% | 255,347 | +13.2% | 0.03% | +28.6% |
Q1 2022 | $16,044,000 | +44.6% | 225,625 | +32.7% | 0.02% | +61.5% |
Q4 2021 | $11,092,000 | -40.1% | 169,965 | -31.1% | 0.01% | -43.5% |
Q3 2021 | $18,504,000 | -1.0% | 246,596 | +2.9% | 0.02% | 0.0% |
Q2 2021 | $18,694,000 | -0.8% | 239,581 | +4.1% | 0.02% | -4.2% |
Q1 2021 | $18,850,000 | +17.2% | 230,166 | +18.3% | 0.02% | +14.3% |
Q4 2020 | $16,083,000 | +44.4% | 194,494 | +13.5% | 0.02% | +31.2% |
Q3 2020 | $11,137,000 | +3.8% | 171,379 | -1.0% | 0.02% | -5.9% |
Q2 2020 | $10,725,000 | +4.8% | 173,175 | +8.4% | 0.02% | -19.0% |
Q1 2020 | $10,234,000 | +369.2% | 159,823 | +328.0% | 0.02% | +425.0% |
Q1 2019 | $2,181,000 | +9382.6% | 37,338 | +9804.0% | 0.00% | – |
Q4 2018 | $23,000 | -20.7% | 377 | 0.0% | 0.00% | – |
Q3 2018 | $29,000 | -25.6% | 377 | -34.9% | 0.00% | – |
Q2 2018 | $39,000 | -4.9% | 579 | -19.4% | 0.00% | – |
Q1 2018 | $41,000 | – | 718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |